GUPharma Releases Its 2023 Sustainability Report
GUPharma, a prominent global Contract Research, Development & Manufacturing Organization (CRO-CDMO), proudly announces the publication of its 2023 Sustainability Report....
GUPharma Expands DMPK Capabilities to Support Large-Scale Collaborations
To better serve its global pharmaceutical clients, GUPharma has significantly enhanced its drug metabolism and pharmacokinetics (DMPK) services. This expansion...
GUPharma Strengthens Its Discovery Leadership
GUPharma is excited to announce the expansion of its leadership team with the addition of Dr. Atul Tiwari as Vice...
GUPharma Celebrates Silver Jubilee Year; Surpasses Milestone Ahead of Schedule
Entering its Silver Jubilee year, GUPharma celebrates early achievement of its vision—supporting the development of 25 new medicines by 2025....
GUPharma Joins the Science Based Targets Initiative (SBTi)
In its commitment to combating climate change, GUPharma has joined the Science Based Targets initiative (SBTi). The company is dedicated...
GUPharma Unveils New High-Potency API Manufacturing Facility
GUPharma announces the opening of a new High-Potency API (HPAPI) manufacturing facility at its Bidar campus. This facility is designed...
